Three MIPS researchers recognised by British Pharmacological Society

Three researchers from the Drug Discovery Biology theme at the Monash Institute of Pharmaceutical Sciences have received prestigious awards from the British Pharmacological Society.

Professor Patrick Sexton, Theme Leader, Drug Discovery Biology, has been awarded the Vane Medal.

The prize was established in 2001 in honour of the English pharmacologist Sir John Vane. Formerly known as the JR Vane Medal, this honour is awarded annually for outstanding work in any research area. Professor Sexton was cited for his outstanding work in the study of structure-function of G protein-coupled receptors (GPCRs).

Professor Roger Summers has been named an Honorary Fellow. Honorary Fellowship is the highest honour bestowed by the British Pharmacological Society. It is awarded to senior members (or exceptionally to non-members) distinguished for their sustained leadership role in science.

Professor Summers was recognised for his sustained leadership on the molecular pharmacology of GPCRs.

Doctor Christopher Langmead, Head, Servier Program in Drug Discovery, has been awarded the Novartis Prize.

This award was created by the British Pharmacological Society in 1972 to recognize the achievements in research of members, and was known as the Sandoz Prize until 1997. Winners are assessed on their published work, which must include papers published in the British Journal of Pharmacology, British Journal of Clinical Pharmacology or Pharmacology Research & Perspectives.

Chris Porter, MIPS Director, commented ‘Individually, these awards represent very significant achievements and provide international recognition of research leadership. For all three to be awarded in the same year to MIPS researchers provides fantastic recognition of the strength and depth of MIPS research in Drug Discovery Biology, and in particular, in GPCR research. Many congratulations to all the recipients’.